Randomized, prospective, efficacy and pharmacoeconomic trial of short course combination antiviral of lamivudine and adefovir versus entecavir monotherapy in HBeAg-positive chronic hepatitis B

ZB He; QY Chen; JS Zhu; ZM Lin; MG Cai; XH Feng; KZ Liu

doi:10.5897/AJMR12.782

African Journal of
Microbiology Research

Abbreviation: Afr. J. Microbiol. Res.
Language: English
ISSN: 1996-0808
DOI: 10.5897/AJMR
Start Year: 2007
Published Articles: 5233

Full Length Research Paper

Randomized, prospective, efficacy and pharmacoeconomic trial of short course combination antiviral of lamivudine and adefovir versus entecavir monotherapy in HBeAg-positive chronic hepatitis B

ZB He1*, QY Chen1, JS Zhu2, ZM Lin2, MG Cai2, XH Feng2 and KZ Liu3

1The Fifth People’s Hospital of Shanghai, Fudan University Shanghai 200240, China. 2Taizhou Hospital of Zhejiang Province, Wenzhou Medical College China. 3The First Affiliated Hospital of college of Medicine, Zhejiang University China.
Email: [email protected]

Article Number - FCF603216959
Vol.7(17), pp. 1688-1696 , April 2013
https://doi.org/10.5897/AJMR12.782

Accepted: 25 March 2013
Published: 23 April 2013

Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0.